PEP/NEWS — Peptide intel. Daily.

N-Acetyl Cysteine: http://bit.ly/2MwBtnO 5 AMAZING Facts About NAC ( N-Acetyl Cysteine) You Didn't Know is a video that looks at the health benefits of nac. N acetylcysteine is key to improving your health naturally with many science backe

Join my NEW menopause community for women: https://www.skool.com/drtyna EP. 277: In this episode, I’m sitting down with my longtime friend and microbiome expert Kiran Krishnan from Just Thrive for a conversation I have been WAITING to have

Apply here to work 1:1 with me and my team: https://linktw.in/TQNxOy Or Follow me and DM “BIOHACK” on Instagram @realnicktrigili: https://www.instagram.com/realnicktrigili/ Chapters: 0:00 Morning Wood Is Your #1 Health Biomarker (Not Tes

Join this casual Q&A session to catch up on the latest channel updates and get answers to your recent questions. After a brief summer break, I am sitting down to reconnect with the community. This video focuses on addressing the feedback,

Rare FNIP1 mutations showed up linked to better metabolic profiles and much lower cardiometabolic disease risk across one million participants. Researchers confirmed the finding in human liver cells and mice.

Epigenetic, proteomic, and transcriptomic age clocks are attracting billions in venture capital. A new analysis warns that without regulatory clarity, those investments may rest on metrics that don't yet qualify as validated endpoints.

Insilico Medicine previewed a Virtual Aging Cell platform that treats biological age as a conditional variable across six scales — molecular to organism. It is the first platform to model how a cell's state shifts over time, not just what it looks like at a single snapshot.

AgelessRx secured a $1 million milestone award in the $101 million XPRIZE Healthspan competition. Their model — personalized aging care via telehealth — is now one of ten finalists vying for the main prize.

A specialist at a longevity clinic describes the practical frustration of acting on early biomarkers when treatment guidelines haven't caught up. The gap between detection and intervention is real — and growing.

Insilico Medicine launched a benchmark designed to test whether AI can actually discover new medicines — not just perform well on curated academic datasets. The question being asked is sharper than it sounds.

Mesoblast finished dosing all 350 patients in its Phase 3 trial of rexlemestrocel-L for chronic low back pain tied to degenerative disc disease. The primary endpoint is durable pain reduction — results will be a key data point for regenerative cell therapy.

A new paper in Aging Cell maps how GLP-1 (glucagon-like peptide-1) signaling connects to mitochondrial function as animals age. The axis may explain some of the metabolic benefits seen in GLP-1 class drugs beyond simple appetite suppression.

A research team built Pasta, a transcriptomic clock that predicts how specific compounds and gene expression changes affect biological age. It offers a different angle from methylation-based epigenetic clocks — and may be more responsive to short-term interventions.

Part one of a three-part deep dive covers cancer biology basics and identifies which pathways are most relevant to peptide research. A solid foundation before reading the more applied parts of the series.